Anne P Starling1, John L Adgate2, Richard F Hamman3, Katerina Kechris4, Antonia M Calafat5, Dana Dabelea6. 1. Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA; Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Electronic address: anne.starling@ucdenver.edu. 2. Department of Environmental and Occupational Health, Colorado School of Public Health, Aurora, CO, USA. 3. Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA; Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 4. Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA. 5. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. 6. Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA; Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Abstract
BACKGROUND: Prenatal exposures to certain per- and polyfluoroalkyl substances (PFAS) have been linked to lower weight and adiposity at birth but greater weight and adiposity in childhood. We hypothesized that faster growth in early infancy may be associated with maternal PFAS concentrations. METHODS: Among 415 mother-infant pairs in a longitudinal cohort study, we estimated associations between maternal pregnancy serum concentrations of six PFAS and offspring weight and adiposity at ~5 months of age, and growth in early infancy. Linear and logistic regression models were adjusted for potential confounders including maternal pre-pregnancy body mass index. Effect modification by infant sex was evaluated. We evaluated potential confounding by correlated exposures via multipollutant linear regression and elastic net penalized regression. RESULTS: Associations between maternal PFAS concentrations and infant weight and adiposity differed by offspring sex. In male infants, maternal perfluorooctanoate and perfluorononanoate were positively associated with adiposity, with percent fat mass increases of 1.5-1.7% per ln-ng/mL increase in PFAS (median adiposity at ~5 months: 24.6%). Maternal perfluorooctane sulfonate (PFOS) and perfluorohexane sulfonate (PFHxS) were associated with lower weight-for-age z-score among female infants only (-0.26 SD per ln-ng/mL PFOS, 95% CI -0.43, -0.10; -0.17 SD per ln-ng/mL PFHxS, 95% CI -0.33, -0.01). In analyses pooled by sex, 2-(N-methyl-perfluorooctane sulfonamido) acetate above vs. below the limit of detection was associated with greater odds of rapid growth in weight-for-age (odds ratio [OR] 2.2, 95% CI 1.1, 4.3) and weight-for-length (OR 3.3, 95% CI 1.8, 6.2). Multipollutant models generally confirmed the results and strengthened some associations. DISCUSSION: We observed sex- and chemical-specific associations between maternal serum PFAS concentrations and infant weight and adiposity. Multipollutant models suggested confounding by correlated PFAS with opposing effects. Although maternal PFAS concentrations are inversely associated with infant weight and adiposity at birth, rapid gain may occur in infancy, particularly in fat mass.
BACKGROUND: Prenatal exposures to certain per- and polyfluoroalkyl substances (PFAS) have been linked to lower weight and adiposity at birth but greater weight and adiposity in childhood. We hypothesized that faster growth in early infancy may be associated with maternal PFAS concentrations. METHODS: Among 415 mother-infant pairs in a longitudinal cohort study, we estimated associations between maternal pregnancy serum concentrations of six PFAS and offspring weight and adiposity at ~5 months of age, and growth in early infancy. Linear and logistic regression models were adjusted for potential confounders including maternal pre-pregnancy body mass index. Effect modification by infant sex was evaluated. We evaluated potential confounding by correlated exposures via multipollutant linear regression and elastic net penalized regression. RESULTS: Associations between maternal PFAS concentrations and infant weight and adiposity differed by offspring sex. In male infants, maternal perfluorooctanoate and perfluorononanoate were positively associated with adiposity, with percent fat mass increases of 1.5-1.7% per ln-ng/mL increase in PFAS (median adiposity at ~5 months: 24.6%). Maternal perfluorooctane sulfonate (PFOS) and perfluorohexane sulfonate (PFHxS) were associated with lower weight-for-age z-score among female infants only (-0.26 SD per ln-ng/mL PFOS, 95% CI -0.43, -0.10; -0.17 SD per ln-ng/mL PFHxS, 95% CI -0.33, -0.01). In analyses pooled by sex, 2-(N-methyl-perfluorooctane sulfonamido) acetate above vs. below the limit of detection was associated with greater odds of rapid growth in weight-for-age (odds ratio [OR] 2.2, 95% CI 1.1, 4.3) and weight-for-length (OR 3.3, 95% CI 1.8, 6.2). Multipollutant models generally confirmed the results and strengthened some associations. DISCUSSION: We observed sex- and chemical-specific associations between maternal serum PFAS concentrations and infant weight and adiposity. Multipollutant models suggested confounding by correlated PFAS with opposing effects. Although maternal PFAS concentrations are inversely associated with infant weight and adiposity at birth, rapid gain may occur in infancy, particularly in fat mass.
Authors: Christopher Lau; Julie R Thibodeaux; Roger G Hanson; Michael G Narotsky; John M Rogers; Andrew B Lindstrom; Mark J Strynar Journal: Toxicol Sci Date: 2006-01-16 Impact factor: 4.849
Authors: Megan E Romano; Yingying Xu; Antonia M Calafat; Kimberly Yolton; Aimin Chen; Glenys M Webster; Melissa N Eliot; Cynthia R Howard; Bruce P Lanphear; Joseph M Braun Journal: Environ Res Date: 2016-05-11 Impact factor: 6.498
Authors: Camilla Schou Andersen; Chunyuan Fei; Michael Gamborg; Ellen A Nohr; Thorkild I A Sørensen; Jørn Olsen Journal: Am J Epidemiol Date: 2013-07-03 Impact factor: 4.897
Authors: Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal Journal: Reprod Toxicol Date: 2016-10-17 Impact factor: 3.143
Authors: Sharon K Sagiv; Sheryl L Rifas-Shiman; Abby F Fleisch; Thomas F Webster; Antonia M Calafat; Xiaoyun Ye; Matthew W Gillman; Emily Oken Journal: Am J Epidemiol Date: 2018-04-01 Impact factor: 4.897
Authors: Richard Christian Jensen; Marianne S Andersen; Pia Veldt Larsen; Dorte Glintborg; Christine Dalgård; Clara Amalie Gade Timmermann; Flemming Nielsen; Maria Boysen Sandberg; Helle Raun Andersen; Henrik Thybo Christesen; Philippe Grandjean; Tina Kold Jensen Journal: Environ Health Perspect Date: 2020-07-06 Impact factor: 9.031
Authors: Michael S Bloom; Sarah Commodore; Pamela L Ferguson; Brian Neelon; John L Pearce; Anna Baumer; Roger B Newman; William Grobman; Alan Tita; James Roberts; Daniel Skupski; Kristy Palomares; Michael Nageotte; Kurunthachalam Kannan; Cuilin Zhang; Ronald Wapner; John E Vena; Kelly J Hunt Journal: Environ Res Date: 2021-07-31 Impact factor: 6.498
Authors: Mathilde Lolk Thomsen; Louise Scheutz Henriksen; Jeanette Tinggaard; Flemming Nielsen; Tina Kold Jensen; Katharina M Main Journal: Environ Health Date: 2021-06-28 Impact factor: 5.984
Authors: Yun Jeong Lee; Hae Woon Jung; Hwa Young Kim; Yoon-Jung Choi; Young Ah Lee Journal: Front Endocrinol (Lausanne) Date: 2021-09-09 Impact factor: 5.555